47 results on '"Lee, Hyoung-Gon"'
Search Results
2. The sterol regulatory element-binding protein 2 is dysregulated by tau alterations in Alzheimer disease
3. P3-029: Oxidative damage is correlated with mitochondrial autophagy
4. Oxidative Damage is Correlated with Mitochondrial Autophagy
5. P1‐400: DEVELOPMENT OF CURCUMIN/MELATONIN HYBRIDS AND THEIR POTENTIAL APPLICATION IN AD
6. P1-106: ABERRANT ACTIVATION OF PKC-THETA IN ALZHEIMER'S DISEASE AND ITS ROLE IN NEURONAL INSULIN RESISTANCE
7. Down‐regulation of serum gonadotropins but not estrogen replacement improves cognition in aged‐ovariectomized 3xTg AD female mice
8. Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance
9. P3-067: Neuronal leptin resistance in Alzheimer's disease
10. P2–014: Presenilin mutations impair mitochondrial dynamics in neurons
11. P1-110: Space-like radiation causes accelerated cognitive impairment and increased Alzheimer's-like pathology in CRND8 APP transgenic mice
12. O3-04-03: Identification of a signal transduction mechanism of amyloid-β/PrPC interaction
13. Neuroendocrinology-based therapy for Alzheimer's disease
14. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease
15. Mark A. Smith: The Scientist, the Man
16. P2‐299: Cell cycle aberrations mediate neurotoxicity induced by soluble amyloid‐beta oligomers
17. Analysis of intracellular amyloid‐β as a consistent feature of hippocampal neurons
18. P2-316: Disturbance in AMP-activated protein kinase (AMPK) signaling pathway in Alzheimer's disease
19. P1-200: Association of leptin receptor with neurofibrillary tangles of Alzheimer disease
20. P1-287: Neuronal cell cycle re-entry as a neurotoxic mechanism of soluble amyloid oligomers in hippocampal slice cultures
21. P2-300: Abnormal activation of protein kinase C theta in Alzheimer's disease: Pathological implications
22. Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer’s disease
23. Widespread distribution of reticulon-3 in various neurodegenerative diseases
24. Down-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits
25. F5-02-02: Cell cycle mediated neurodegeneration
26. P3-073: Dissociated Aβ antibody level in newly diagnosed Alzheimer's disease: A population-based study
27. The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells
28. Antigenantibody dissociation in Alzheimer disease: a novel approach to diagnosis
29. P1‐351: A novel approach to diagnosis: Antigen‐antibody disassociation in Alzheimer's disease
30. P3‐317: Failure in the control of cell cycle causes neurodegeneration
31. Antibody‐Antigen Dissociation: A Novel Diagnostic Tool in Alzheimer Disease
32. Neurodegenerative Phenotypes Induced by MYC‐Driven Neuronal Cell Cycle Re‐entry: Relevance to Alzheimer Disease
33. P1-388: Failure of cytoplasmic-nuclear transport in Alzheimer's disease
34. P3-372: Oxidative stress and prion protein mutations
35. S5–02–04: Cell cycle re–entry mediates Alzheimer–type changes in neurons in vitro
36. P1-417: Ectopic localization of phospho-Smad2 in the vulnerable neurons of Alzheimer's disease
37. Increased Expression of Calsenilin in the Brains of Scrapie-infected Mice
38. Ectopic expression of phospho-Smad2 in Alzheimer's disease: Uncoupling of the transforming growth factor-β pathway?
39. Amyloid-β in Alzheimer's disease: the horse or the cart? Pathogenic or protective?
40. Mitogen‐ and stress‐activated protein kinase 1: Convergence of the ERK and p38 pathways in Alzheimer's disease
41. Challenging the Amyloid Cascade Hypothesis: Senile Plaques and Amyloid-β as Protective Adaptations to Alzheimer Disease
42. Neuroprotective properties of Bcl‐w in Alzheimer disease
43. Distribution, levels, and activation of MEK1 in Alzheimer's disease
44. Will Preventing Protein Aggregates Live Up to Its Promise as Prophylaxis Against Neurodegenerative Diseases?
45. Increased p27, an essential component of cell cycle control, in Alzheimer's disease
46. Overexpression of Calsenilin in Sporadic Alzheimer's Disease Brain
47. Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.